Evena Medical launches DeepVu Ultrasound 4.0

Evena Medical, based in Los Altos, Calif., has launched DeepVu Ultrasound 4.0, an advanced mobile ultrasound medical imaging system.

The company made the announcement at MEDICA trade fair in Dusseldorf, Germany.

The enhanced ultrasound delivers real-time bedside imaging with clear and accurate results and a cart free system. All of the images will be able to wirelessly connect anywhere within the facility to PCs, iPads or hands-free on the Evena Eyes-On Clinical Glasses for wearable imaging.

“The DeepVu Ultrasound 4.0 system offers medical professionals an advanced mobile and wearable ultrasound option for adult primary care, pediatrics, emergency medical care and other medical specialties,” Frank Ball, Evena Medical, CEO said in a statement.  “With Evena’s Eyes-On Glasses, clinicians can visualize veins, organs and other tissue deep beneath the skin with superior, real-time imaging in front of their eyes with simple, hands-free operation.”

The Eyes-On platform is one of the first healthcare applications to deliver these smart glasses created by clinicians and made for clinicians. Evena Medical states that this technology not only produces high quality images, but also does so without the image latency problems, thus becoming extremely useful in even the worst of conditions.

“With Evena’s wearable U/S and AR platform, doctors, nurses and medics can quickly and easily view important patient imagery – even in challenging clinical environments such as emergency, surgical, or pre-hospital, or in more remote, underdeveloped parts of the world without access to advanced medical care.”

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.